Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,659
+36.19%
|
-
|
|
Jun 01
2023
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,659
+41.82%
|
-
|
|
Jun 01
2023
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,659
+36.89%
|
-
|
|
Jun 01
2023
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,659
+35.55%
|
-
|
|
Jun 01
2023
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,659
+29.22%
|
-
|
|
May 19
2023
|
Melissa Baird Chief Operating Officer |
BUY
Other acquisition or disposition
|
Direct |
2,500
+0.58%
|
$7,500
$3.0 P/Share
|
|
May 10
2023
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,966
+2.89%
|
$0
$0.4 P/Share
|
|
May 09
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,966
-1.5%
|
$129,660
$10.78 P/Share
|
|
May 09
2023
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,966
+2.89%
|
$0
$0.4 P/Share
|
|
May 08
2023
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,032
+4.31%
|
$0
$0.4 P/Share
|
|
May 08
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,966
-1.57%
|
$142,626
$11.83 P/Share
|
|
May 05
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,032
-2.21%
|
$228,384
$12.04 P/Share
|
|
May 04
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
566
-100.0%
|
$6,226
$11.68 P/Share
|
|
May 04
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
566
+50.0%
|
$566
$1.75 P/Share
|
|
Apr 06
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,233
-2.3%
|
$92,097
$9.89 P/Share
|
|
Apr 05
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,633
-1.06%
|
$86,697
$9.93 P/Share
|
|
Apr 04
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,432
-2.17%
|
$204,320
$10.08 P/Share
|
|
Apr 04
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
15,890
-100.0%
|
$158,900
$10.3 P/Share
|
|
Apr 04
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
567
+50.0%
|
$567
$1.75 P/Share
|
|
Mar 20
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,333
-1.92%
|
$83,997
$9.54 P/Share
|
|
Mar 17
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,745
-7.56%
|
$123,705
$9.79 P/Share
|
|
Mar 17
2023
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,720
-6.98%
|
$141,480
$9.9 P/Share
|
|
Mar 17
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
6,170
-28.71%
|
$55,530
$9.79 P/Share
|
|
Mar 17
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,176
-2.05%
|
$91,584
$9.79 P/Share
|
|
Mar 16
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,943
-0.79%
|
$107,487
$9.94 P/Share
|
|
Mar 15
2023
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,595
-20.65%
|
$50,355
$9.01 P/Share
|
|
Mar 15
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,847
+36.91%
|
-
|
|
Mar 15
2023
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+11.11%
|
-
|
|
Mar 15
2023
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,043
+2.79%
|
-
|
|
Mar 15
2023
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,347
-47.15%
|
$921,123
$9.01 P/Share
|
|
Mar 15
2023
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209,580
+49.12%
|
-
|
|
Mar 15
2023
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+33.33%
|
-
|
|
Mar 15
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,261
-3.84%
|
$65,349
$9.01 P/Share
|
|
Mar 15
2023
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,006
+10.0%
|
-
|
|
Mar 15
2023
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,828
-1.71%
|
$79,452
$9.01 P/Share
|
|
Mar 15
2023
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,280
+6.57%
|
-
|
|
Mar 15
2023
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+10.51%
|
-
|
|
Mar 15
2023
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+20.0%
|
-
|
|
Mar 15
2023
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
565
+7.14%
|
-
|
|
Mar 15
2023
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,726
-11.6%
|
$132,534
$9.01 P/Share
|
|
Mar 15
2023
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,853
+24.35%
|
-
|
|
Mar 15
2023
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,286
+15.58%
|
-
|
|
Mar 15
2023
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+11.11%
|
-
|
|
Mar 15
2023
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,043
+50.0%
|
-
|
|
Mar 15
2023
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,122
-9.63%
|
$370,098
$9.01 P/Share
|
|
Mar 15
2023
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,454
+15.18%
|
-
|
|
Mar 14
2023
|
Jules A. Maltz Director |
BUY
Other acquisition or disposition
|
Indirect |
2,449
+50.0%
|
-
|
|
Mar 14
2023
|
Jules A. Maltz Director |
SELL
Other acquisition or disposition
|
Direct |
2,449
-11.74%
|
-
|
|
Mar 14
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.18%
|
$18,000
$9.09 P/Share
|
|
Mar 08
2023
|
David B Wells Director |
SELL
Open market or private sale
|
Direct |
100,000
-22.71%
|
$900,000
$9.77 P/Share
|